皮膚科學習園地
Case:
- 21YOM HSP with abdomen and joint involvement
- 89YOM Drug eruption, anti-TB drug related
- 87YOM cellulitis with ulceration over keloid
Resourse:
- MedPartner | 皮膚疾病
- Journal of the American Academy of Dermatology
- Fitzpatrick's Dermatology in General Medicine, 8e
指導醫師:吳介山、張喬勝、曾慧文、魏楷哲
Section 1. General Considerations
1 The Epidemiology and Burden of
Skin Disease. . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . 1
Martin A. Weinstock, MD, PhD &
Mary-Margaret Chren, MD
2 Evidence-Based Dermatology. . . . . . . . . .
. . . . . . . . 9
Michael Bigby, MD,
Rosamaria Corona, DSc, MD, &
Moyses Szklo, MD, MPH, DrPH
3 Global Health in Dermatology. . . . . . . . .
. . . . . . . 15
Roderick J. Hay, DM, FRCP, FRCPath, FMedSci
4 Public Health in Dermatology. . . . . . . . .
. . . . . . . . 21
Hywel C. Williams, MSc, PhD, FRCP,
Sinead M. Langan, MRCP, MSc, PhD, &
Carsten Flohr, BM, BCh (Hons), MA, Mphil,
MRCPCH, MSc, PhD
Section 2. Approach to Dermatologic Diagnosis
5 Structure of Skin Lesions and Fundamentals
of Clinical Diagnosis. . . . . . . . . . . .
. . . . . . . . . . . . . 26
Amit Garg, MD, Nikki A. Levin, MD, PhD, &
Jeffrey D. Bernhard, MD, FRCP (Edin)
6 Basic Pathologic Reactions of the Skin. . . .
. . . . . . 42
Martin C. Mihm Jr., MD, FACP,
Abdul-Ghani Kibbi, MD, FAAD, FACP,
George F. Murphy, MD &
Klaus Wolff, MD, FRCP
Section 3. Overview of Biology, Development,
and Structure of Skin
7 Development and Structure of Skin. . . . . .
. . . . . . 58
David H. Chu, MD, PhD
8 Genetics in Relation to the Skin . . . . . .
. . . . . . . . . 75
John A. McGrath, MD, FRCP &
W. H. Irwin McLean, FRSE, FMedSci
9 Racial Considerations: Skin of Color. . . . .
. . . . . . 91
Kavitha K. Reddy, MD, Yolanda M. Lenzy, MD,
MPH, Katherine L. Brown, MD, MPH, &
Barbara A. Gilchrest, MD
PART
2 Disorder s Pre senting in
Skin
and Mucou s Mem brane s
Section 4. Inflammatory Disorders Bas ed on
T-Cell Reac tivity and Dysregulation
10 Innate and Adaptive Immunity in the Skin. . .
. 105
Robert L. Modlin, MD, Lloyd S. Miller, MD,
PhD,
Christine Bangert, MD, & Georg Stingl, MD
11 Cytokines. . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . 126
Ifor R. Williams, MD, PhD &
Thomas S. Kupper, MD, FAAD
12 Chemokines. . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . 142
Anke S. Lonsdorf, MD &
Sam T. Hwang, MD, PhD
13 Allergic Contact Dermatitis. . . . . . . . .
. . . . . . . . . 152
Mari Paz Castanedo-Tardan, MD &
Kathryn A. Zug, MD
14 Atopic Dermatitis (Atopic Eczema). . . . . .
. . . . . 165
Donald Y.M. Leung, MD, PhD,
Lawrence F. Eichenfield, MD, &
Mark Boguniewicz, MD
15 Nummular Eczema, Lichen Simplex
Chronicus, and Prurigo Nodularis. . . . . . .
. . . . . 182
Susan Burgin, MD
16 Vesicular Palmoplantar Eczema . . . . . . . .
. . . . . . 187
Daven N. Doshi, MD, Carol E. Cheng, MD, &
Alexa B. Kimball, MD, MPH
17 Autosensitization Dermatitis. . . . . . . . .
. . . . . . . . 194
Donald V. Belsito, MD
18 Psoriasis. . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . 197
Johann E. Gudjonsson, MD, PhD &
James T. Elder, MD, PhD
19 Psoriatic Arthritis. . . . . . . . . . . . .
. . . . . . . . . . . . . . 232
Dafna D. Gladman, MD, FRCPC &
Vinod Chandran, MBBS, MD, DM
20 Reactive Arthritis. . . . . . . . . . . . . .
. . . . . . . . . . . . . 243
John D. Carter, MD
21 Pustular Eruptions of Palms and Soles . . . .
. . . . 253
Ulrich Mrowietz, MD
22 Seborrheic Dermatitis. . . . . . . . . . . .
. . . . . . . . . . . 259
Chris D. Collins, MD, FAAD &
Chad Hivnor, MD
23 Exfoliative Dermatitis. . . . . . . . . . . .
. . . . . . . . . . . 266
Jane Margaret Grant-Kels, MD,
Flavia Fedeles, MD, MS, & Marti J. Rothe,
MD
24 Pityriasis Rubra Pilaris. . . . . . . . . . .
. . . . . . . . . . . 279
Daniela Bruch-Gerharz, MD &
Thomas Ruzicka, Prof. Dr. med. Dr. h.c.
25 Parapsoriasis and Pityriasis Lichenoides. . .
. . . . 285
Gary S. Wood, MD, Chung-Hong Hu, MD &
Rosemarie Liu, MD
26 Lichen Planus . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . 296
Mazen S. Daoud, MD & Mark R. Pittelkow,
MD
27 Lichen Nitidus . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . 312
Mazen S. Daoud, MD &
Mark R. Pittelkow, MD
28 Graft-Versus-Host Disease. . . . . . . . . .
. . . . . . . . . 316
Edward W. Cowen, MD, MHSc
29 Skin Disease in Acute and Chronic
Immunosuppression. . . . . . . . . . . . . .
. . . . . . . . . . 330
Benjamin D. Ehst, MD, PhD &
Andrew Blauvelt, MD
Section 5. Inflammatory Diseases Based on
Neutrophils and Eosinophils
30 Regulation of the Production and
Activation of Neutrophils . . . . . . . . . .
. . . . . . . . . 345
Steven M. Holland, MD
31 Regulation of the Production and
Activation of Eosinophils. . . . . . . . . .
. . . . . . . . . . 351
Kristin M. Leiferman, MD, Lisa A. Beck, MD,
&
Gerald J. Gleich, MD
32 Acute Febrile Neutrophilic Dermatosis
(Sweet Syndrome). . . . . . . . . . . . . . .
. . . . . . . . . . . 362
Philip R. Cohen, MD, Herbert Honigsmann, MD,
&
Razelle Kurzrock, MD, FACP
33 Pyoderma Gangrenosum. . . . . . . . . . . . .
. . . . . . . 371
Frank C. Powell, FRCPI, FAAD,
Bridget C. Hackett, MB BCh, BAO, MRCPI, &
Daniel Wallach, MD
34 Granuloma Faciale. . . . . . . . . . . . . .
. . . . . . . . . . . . 380
David A. Mehregan, MD &
Darius R. Mehregan, MD
35 Subcorneal Pustular Dermatosis (Sneddon–
Wilkinson Disease). . . . . . . . . . . . . .
. . . . . . . . . . . . 383
Franz Trautinger, MD &
Herbert Honigsmann, MD
36 Eosinophils in Cutaneous Diseases . . . . . .
. . . . . 386
Kristin M. Leiferman, MD &
Margot S. Peters, MD
Section 6. Inflammatory Diseases Bas ed on
Abnormal Humoral Reactivity and Other Inflammatory Diseases
37 Humoral Immunity and Complement. . . . . . .
. . 401
Lela A. Lee, MD
38 Urticaria and Angioedema. . . . . . . . . . .
. . . . . . . . 414
Allen P. Kaplan, MD
39 Erythema Multiforme. . . . . . . . . . . . .
. . . . . . . . . . 431
Jean-Claude Roujeau, MD
40 Epidermal Necrolysis (Stevens–Johnson
Syndrome and Toxic Epidermal Necrolysis). . .
. . 439
L. Valeyrie-Allanore, MD & Jean-Claude
Roujeau, MD
41 Cutaneous Reactions to Drugs . . . . . . . .
. . . . . . . 449
Neil H. Shear, MD, FRCPC &
Sandra R. Knowles, BScPhm
42 Pityriasis Rosea. . . . . . . . . . . . . . .
. . . . . . . . . . . . . . 458
Andrew Blauvelt, MD
43 Erythema Annulare Centrifugum and Other
Figurate Erythemas. . . . . . . . . . . . . .
. . . . . . . . . . . 463
Walter H.C. Burgdorf, MD
44 Granuloma Annulare . . . . . . . . . . . . .
. . . . . . . . . . 467
Julie S. Prendiville, MB, FRCPC
Section 7. Disorders of Epidermal Differentiation
and Keratinization
45 Epidermal
Stem Cells . . . . . . . . . . . . . . . . . . . . . . . 473
Rebecca J. Morris, PhD
46 Epidermal
Growth and Differentiation. . . . . . . . 478
Pierre A. Coulombe, PhD,
Stanley J. Miller, MD, & Tung-Tien Sun, PhD
47 Skin
as an Organ of Protection. . . . . . . . . . . . . . . 486
Ehrhardt Proksch, MD, PhD &
Jens-Michael Jensen, MD
48 Irritant
Contact Dermatitis. . . . . . . . . . . . . . . . . . . 499
Antoine Amado, MD, Apra Sood, MD, &
James S. Taylor, MD, FAAD
49 The
Ichthyoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 507
Philip Fleckman, MD & John J. DiGiovanna, MD
50 Inherited
Palmoplantar Keratodermas . . . . . . . . 538
Mozheh Zamiri, BSc (Hons), MBChB, MRCP, MD,
Maurice A. M. van Steensel, MD, PhD, &
Colin S. Munro, MD, FRCP (Glasg)
51 Acantholytic
Disorders of the Skin. . . . . . . . . . . . 550
Susan Burge, OBE, DM, FRCP &
Alain Hovnanian, MD, PhD
52 Porokeratosis.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 563
Grainne M. O’Regan,
MRCPI &
Alan D. Irvine, MD, FRCP, FRCPI
Section 8. Disorders of Epidermal and
Dermal–Epidermal Adhesion and Vesicular
and Bullous Disorders
53 Epidermal
and Epidermal–Dermal Adhesion. . . . 569
Leena Bruckner-Tuderman, MD &
Aimee S. Payne, MD, PhD
54 Pemphigus.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 586
Aimee S. Payne, MD, PhD &
John R. Stanley, MD
55 Paraneoplastic
Pemphigus. . . . . . . . . . . . . . . . . . . 600
Grant J. Anhalt, MD & Daniel Mimouni, MD
56 Bullous
Pemphigoid. . . . . . . . . . . . . . . . . . . . . . . . 608
Donna A. Culton, MD, PhD, Zhi Liu, PhD, &
Luis A. Diaz, MD
57 Cicatricial
Pemphigoid. . . . . . . . . . . . . . . . . . . . . . 617
Kim B. Yancey, MD
58 Linear
Immunoglobulin A Dermatosis and
Chronic Bullous Disease of Childhood. . . . . . . . 623
Caroline L. Rao, MD & Russell P. Hall III, MD
59 Pemphigoid
Gestationis (Herpes Gestationis). . . 630
Jeff K. Shornick, MD, MHA
60 Epidermolysis
Bullosa Acquisita. . . . . . . . . . . . . . 634
David T. Woodley, MD & Mei Chen, PhD
61 Dermatitis
Herpetiformis. . . . . . . . . . . . . . . . . . . . 642
Arash Ronaghy, MD, PhD,
Stephen I. Katz, MD, PhD, &
Russell P. Hall III, MD
62 Inherited
Epidermolysis Bullosa. . . . . . . . . . . . . . 649
M. Peter Marinkovich, MD
Section 9. Disorders of the Dermal Connective
Tissue
63 Collagens,
Elastic Fibers, and Other Extracellular
Matrix Proteins of the Dermis. . . . . . . . . . . . . .
. . 666
Thomas Krieg, MD, Monique Aumailley,
Manuel Koch, PhD, Mon-Li Chu, PhD, &
Jouni Uitto, MD, PhD
64 Morphea.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 692
Stephanie Saxton-Daniels, MD &
Heidi T. Jacobe, MD, MSCS
65 Lichen
Sclerosus. . . . . . . . . . . . . . . . . . . . . . . . . . . . 702
Ulrich R. Hengge, MD, MBA
66 Dermal
Hypertrophies and Benign
Fibroblastic/Myofibroblastic Tumors . . . . . . . . . 707
Christine J. Ko, MD
67 Anetoderma
and Other Atrophic
Disorders of the Skin. . . . . . . . . . . . . . . . . .
. . . . . . 718
Catherine Maari, MD &
Julie Powell, MD, FRCPC
68 Ainhum
and Pseudoainhum. . . . . . . . . . . . . . . . . 724
Robert T. Brodell, MD & Stephen E. Helms, MD
69 Acquired
Perforating Disorders . . . . . . . . . . . . . . 727
Julia S. Minocha, MD &
Bethanee J. Schlosser, MD, PhD
Section 10. Disorders of Subcutaneous Tissue
70 Panniculitis.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 732
Iris K. Aronson, MD, Patricia M. Fishman, MD, &
Sophie M. Worobec, MD, FAAD
71 Lipodystrophy.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . 755
Abhimanyu Garg, MD
Section 11. Disorders of Melanocytes
72 Biology
of Melanocytes. . . . . . . . . . . . . . . . . . . . . . 765
Hee-Young Park, PhD & Mina Yaar, MD
73 Albinism and Other Genetic Disorders of
Pigmentation. . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . 781
Thomas J. Hornyak, MD, PhD
74 Vitiligo. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . 792
Stanca A. Birlea, MD, PhD,
Richard A. Spritz, MD & David A. Norris,
MD
75 Hypomelanoses and Hypermelanoses . . . . . .
. . 804
Hilde Lapeere, MD, PhD, Barbara Boone, MD,
PhD,
Sofie De Schepper, MD, PhD, Evelien
Verhaeghe, MD,
Mireille Van Gele, PhD, Katia Ongenae, MD,
PhD,
Nanja Van Geel, MD, PhD, Jo Lambert, MD, PhD,
&
Lieve Brochez, MD, PhD
Section 12. Disorders of the Oral and
Genital Integument
76 Biology and Pathology of the Oral Cavity. . .
. . . 827
Sook-Bin Woo, DMD
77 Diseases and Disorders of the Male Genitalia
. . . 852
Christopher B. Bunker, MD, FRCP
78 Diseases and Disorders of the Female
Genitalia. . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . 878
Lynette J. Margesson, MD, FRCPC &
F. William Danby, MD, FRCPC, FAAD
PART
3 Disorder s of the
Skin
Appendage s
Section 13. Disorders of the Sebaceous
Glands
79 Biology of Sebaceous Glands. . . . . . . . .
. . . . . . . . 893
Amanda M. Nelson, PhD &
Diane M. Thiboutot, MD
80 Acne Vulgaris and Acneiform Eruptions. . . .
. . . 897
Andrea L. Zaenglein, MD,
Emmy M. Graber, MD, & Diane M. Thiboutot,
MD
81 Rosacea. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . 918
Michelle T. Pelle, MD
82 Perioral Dermatitis. . . . . . . . . . . . .
. . . . . . . . . . . . . 925
Leslie P. Lawley, MD & Sareeta R.S.
Parker, MD
Section 14. Disorders of the Eccrine and
Apocrine Glands
83 Biology of Eccrine and Apocrine Glands. . . .
. . . 929
Theodora M. Mauro, MD
84 Disorders of the Eccrine Sweat Glands and
Sweating . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . 936
Robert D. Fealey, MD & Adelaide A.
Hebert, MD
85 Disorders of the Apocrine Sweat Glands. . . .
. . . 947
Christos C. Zouboulis, MD, PhD &
Fragkiski Tsatsou, MD, MSc, BSc
Section 15. Disorders of the Hair and Nails
86 Biology of Hair Follicles. . . . . . . . . .
. . . . . . . . . . . 960
George Cotsarelis, MD &
Vladimir Botchkarev, MD, PhD
87 Keratosis Pilaris and Other Inflammatory
Follicular Keratotic Syndromes. . . . . . . .
. . . . . . . 973
Paradi Mirmirani, MD &
Maureen Rogers, MBBS, FACD
88 Hair Growth Disorders. . . . . . . . . . . .
. . . . . . . . . . 979
Nina Otberg, MD &
Jerry Shapiro, MD, FRCPC, FAAD
89 Biology of Nails and Nail Disorders. . . . .
. . . . . 1009
Antonella Tosti, MD &
Bianca Maria Piraccini, MD, PhD
PART
4 Disorder s Due to the
Environment
Section 16. Disorders Due to Ultraviolet Radiation
90 Fundamentals of Cutaneous Photobiology and
Photoimmunology. . . . . . . . . . . . . . .
. . . . . . . . . . 1031
Irene E. Kochevar, PhD,
Charles R. Taylor, MD, & Jean Krutmann,
MD
91 Abnormal Responses to Ultraviolet Radiation:
Idiopathic, Probably Immunologic, and
Photoexacerbated. . . . . . . . . . . . . . .
. . . . . . . . . . . 1049
Travis W. Vandergriff, MD &
Paul R. Bergstresser, MD
92 Abnormal Responses to Ultraviolet
Radiation: Photosensitivity Induced by
Exogenous Agents. . . . . . . . . . . . . . .
. . . . . . . . . . 1066
Henry W. Lim, MD
Section 17. Skin Changes Due to Other
Physical and Chemical Factors
93 Thermoregulation . . . . . . . . . . . . . .
. . . . . . . . . . . 1075
Dean L. Kellogg, Jr., MD, PhD
94 Cold Injuries. . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . 1079
Gerald E. Pierard, MD, PhD,
Pascale Quatresooz, MD, PhD, &
Claudine Pierard-Franchimont, MD, PhD
95 Thermal Injuries. . . . . . . . . . . . . . .
. . . . . . . . . . . . 1089
Robert L. Sheridan, MD
96 Skin Problems in Amputees. . . . . . . . . .
. . . . . . . 1095
Calum C. Lyon, MA, FRCP &
Michael H. Beck, FRCP, MBChB
97 Skin Problems in Ostomates . . . . . . . . .
. . . . . . . 1104
Calum C. Lyon, MA, FRCP &
Michael H. Beck, FRCP, MBChB
98 Corns and Calluses . . . . . . . . . . . . .
. . . . . . . . . . . 1111
Thomas M. DeLauro, DPM &
Nicole M. DeLauro, DPM
99 Sports Dermatology. . . . . . . . . . . . . .
. . . . . . . . . . 1115
Dirk M. Elston, MD
100
Decubitus (Pressure) Ulcers . . . . . . . . .
. . . . . . . 1121
Jennifer G. Powers, MD, Lillian Odo, MD,
&
Tania J. Phillips, MD, FRCP, FRCPC
101
Body Art . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . 1129
Anne Laumann, MBChB, MRCP(UK), FAAD
Section 18. Neurocutaneous and Psychocutaneous
Skin Disease
102
Neurobiology of the Skin. . . . . . . . . . .
. . . . . . . . 1137
Martin Steinhoff, MD, PhD &
Thomas A. Luger, MD
103
Pathophysiology and Clinical Aspects
of Pruritus. . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . 1146
Gil Yosipovitch, MD &
Tejesh S. Patel, MBBS (Lon), BSc (Hons)
104
Psychocutaneous Skin Disease . . . . . . . .
. . . . . . 1158
Evan Rieder, MD & Francisco A. Tausk, MD
105
Cutaneous Manifestations of Drug Abuse. . . .
. 1166
Haley Naik, MD & Richard Allen Johnson,
MDCM
106
Skin Signs of Physical Abuse. . . . . . . . .
. . . . . . . 1177
Howard B. Pride, MD
PART
6 SKI N CH ANGES ACROSS
THE
SPAN OF LIFE
Section 19. From Birth to Old Age
107 Neonatal, Pediatric, and Adolescent
Dermatology. . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . 1185
Mary Wu Chang, MD
108 Skin Changes and Diseases in Pregnancy. . . .
. 1204
Julie K. Karen, MD &
Miriam Keltz Pomeranz, MD
109 Aging of Skin . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . 1213
Mina Yaar, MD & Barbara A. Gilchrest, MD
PART
7 NEOPLASI A
Section 20. Carcinogenesis
110
Genome Instability, DNA Repair, and
Cancer. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . 1227
Thomas M. Rünger, MD, PhD &
Kenneth H. Kraemer, MD
111
Chemical Carcinogenesis. . . . . . . . . . .
. . . . . . . . 1239
Adam B. Glick, PhD & Andrzej A. Dlugosz,
MD
112
Ultraviolet Radiation Carcinogenesis . . . .
. . . . 1251
Masaoki Kawasumi, MD, PhD &
Paul Nghiem, MD, PhD
Section 21. Epidermal and App endageal
Tumors
113
Epithelial Precancerous Lesions. . . . . . .
. . . . . . 1261
Karynne O. Duncan, MD,
John K. Geisse, MD & David J. Leffell, MD
114
Squamous Cell Carcinoma. . . . . . . . . . .
. . . . . . . 1283
Douglas Grossman, MD, PhD & David J.
Leffell, MD
115
Basal Cell Carcinoma . . . . . . . . . . . .
. . . . . . . . . . 1294
John A. Carucci, MD, PhD,
David J. Leffell, MD & Julia S.
Pettersen, MD
116
Basal Cell Nevus Syndrome . . . . . . . . . .
. . . . . . 1304
Anthony E. Oro, MD, PhD &
Jean Y. Tang, MD, PhD
117
Keratoacanthoma. . . . . . . . . . . . . . .
. . . . . . . . . . . 1312
Lorenzo Cerroni, MD & Helmut Kerl, MD
118
Benign Epithelial Tumors,
Hamartomas, and Hyperplasias. . . . . . . . .
. . . . 1319
Valencia D. Thomas, MD, Nicholas R. Snavely,
MD,
Ken K. Lee, MD & Neil A. Swanson, MD
119
Appendage Tumors and Hamartomas
of the Skin. . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . 1337
Divya Srivastava, MD & R. Stan Taylor, MD
120
Merkel Cell Carcinoma. . . . . . . . . . . .
. . . . . . . . . 1362
Andrew Tegeder, MS, Olga Afanasiev, BA, &
Paul Nghiem, MD, PhD
121
Mammary and Extramammary
Paget’s Disease. . . . . . . . . . . . . . . . . . . . . . . . . . . .
1371
Sherrif F. Ibrahim, MD, PhD, Roy C. Grekin,
MD, &
Isaac M. Neuhaus, MD
Section 22. Melanocytic Tumors
122 Benign
Neoplasias and Hyperplasias of
Melanocytes. . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . 1377
James M. Grichnik, MD, PhD,
Arthur R. Rhodes, MD, MPH, &
Arthur J. Sober, MD
123 Atypical
(Dysplastic) Melanocytic Nevi. . . . . . 1410
James M. Grichnik, MD, PhD &
Margaret A. Tucker, MD
124 Cutaneous
Melanoma. . . . . . . . . . . . . . . . . . . . . . 1416
Evans C. Bailey, MD, PhD,
Arthur J. Sober, MD, Hensin Tsao, MD, PhD,
Martin C. Mihm Jr, MD, FACP, &
Timothy M. Johnson, MD
Section 23. Tumors and Hyperplasias of the
Dermis and Subc utaneous Fat
125 Malignant
Fibrous, Fibrohistiocytic, and
Histiocytic Tumors of the Dermis. . . . . . . . . . . .
1445
Jürgen C.
Becker, MD, PhD,
Bernadette Liegl-Atzwanger, MD & Selma Ugurel, MD
126 Vascular
Tumors . . . . . . . . . . . . . . . . . . . . . . . . . . 1456
Erin F. Mathes, MD & Ilona J. Frieden, MD
127 Neoplasias
and Hyperplasias of
Muscular and Neural Origin. . . . . . . . . . . . . . . .
1470
Lucile E. White, MD, Ross M. Levy, MD, &
Murad Alam, MD, MSci
128 Kaposi’s Sarcoma and Angiosarcoma. . . . . . . . 1481
Erwin Tschachler, MD
129 Neoplasms
of Subcutaneous Fat. . . . . . . . . . . . . 1489
Thomas Brenn, MD, PhD, FRCPath
Section 24. Skin in Nutritional, Metabolic,
and Heritable Disease
130 Cutaneous
Changes in Nutritional Disease. . . . 1499
Melinda Jen, MD & Albert C. Yan, MD
131 Cutaneous
Changes in Errors of
Amino Acid Metabolism. . . . . . . . . . . . . . . . . .
. . 1525
Peter H. Itin, MD
132 The
Porphyrias. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1538
David R. Bickers, MD & Jorge Frank, MD, PhD
133 Amyloidosis
of the Skin. . . . . . . . . . . . . . . . . . . . 1574
Helen J. Lachmann, MD, FRCP &
Philip N. Hawkins, PhD, FRCP, FRCPath, FMedSci
134 Systemic
Autoinflammatory Diseases. . . . . . . . 1584
Chyi-Chia Richard Lee, MD, PhD &
Raphaela Goldbach-Mansky, MD, MHS
135 Xanthomatoses
and Lipoprotein Disorders. . . . 1600
Ernst J. Schaefer, MD & Raul D. Santos, MD, PhD
136 Fabry
Disease. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1613
Atul B. Mehta, MD, FRCP, FRCPath &
Catherine H. Orteu, MBBS, BSc, MD, FRCP
137 Lipoid
Proteinosis and Heritable
Disorders of Connective Tissue. . . . . . . . . . . . . .
1624
Jonathan A. Dyer, MD
138 Cutaneous
Mineralization and Ossification. . . .
1649
Janet A. Fairley, MD
139 Hereditary
Disorders of Genome
Instability and DNA Repair. . . . . . . . . . . . . . . .
. 1654
Thomas M. Rünger, MD,
PhD,
John J. DiGiovanna, MD, &
Kenneth H. Kraemer, MD
140 Tuberous
Sclerosis Complex . . . . . . . . . . . . . . . . 1671
Thomas N. Darling, MD, PhD
141 The
Neurofibromatoses. . . . . . . . . . . . . . . . . . . . 1680
Robert Listernick, MD & Joel Charrow, MD
142 Ectodermal
Dysplasias. . . . . . . . . . . . . . . . . . . . . 1691
Alanna F. Bree, MD, Nnenna Agim, MD, &
Virginia P. Sybert, MD
143 Genetic
Immunodeficiency Diseases. . . . . . . . . 1703
Ramsay L. Fuleihan, MD & Amy S. Paller, MD
Section 25. Skin Manifestations of Bone
Marrow or Blood Chemistry Disorders
144 Hematologic
Diseases. . . . . . . . . . . . . . . . . . . . . . 1726
Warren W. Piette, MD
145 Cutaneous
Lymphoma. . . . . . . . . . . . . . . . . . . . . 1745
Marc Beyer, MD & Wolfram Sterry, Prof. Dr.
146 Inflammatory
Diseases That Simulate Lymphomas:
Cutaneous Pseudolymphomas. . . . . . . . . . . . . . .
1767
Gary S. Wood, MD
147 Cutaneous
Langerhans Cell Histiocytosis. . . . . 1782
Carlo Gelmetti, MD
148 Non-Langerhans
Cell Histiocytosis. . . . . . . . . . 1795
Carlo Gelmetti, MD
149
Mastocytosis. . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . 1809
Michael D. Tharp, MD
Section 26. Skin Ma nifestations of Internal
Orga n Disorders
150
The Skin and Disorders of the Alimentary
Tract, the Hepatobiliary System, the Kidney,
and the Cardiopulmonary System. . . . . . . .
. . . 1819
Graham A. Johnston, MBChB, FRCP &
Robin A.C. Graham-Brown, BSc, MB, FRCP,
FRCPCH
151
Diabetes Mellitus and Other Endocrine
Diseases. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . 1840
Andrea A. Kalus, MD,
Andy J. Chien, MD, PhD, &
John E. Olerud, MD
152
Sarcoidosis. . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . 1869
Richard M. Marchell, MD, Bruce Thiers, MD,
&
Marc A. Judson, MD
153
Cutaneous Manifestations of Internal
Malignant Disease: Cutaneous
Paraneoplastic Syndromes. . . . . . . . . . .
. . . . . . . 1880
Christine A. DeWitt, MD,
Lucinda S. Buescher, MD, & Stephen P.
Stone, MD
Section 27. The Skin in Vascular and
Connective Tissue and Other Autoimmune Disorders
154
Mechanisms of Autoimmune Disease. . . . . . .
. 1901
Insoo Kang, MD & Joseph Craft, MD
155
Lupus Erythematosus. . . . . . . . . . . . .
. . . . . . . . . 1909
Melissa I. Costner, MD &
Richard D. Sontheimer, MD
156
Dermatomyositis. . . . . . . . . . . . . . .
. . . . . . . . . . . 1926
Richard D. Sontheimer, MD,
Christopher B. Hansen, MD, &
Melissa I. Costner, MD
157
Scleroderma. . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . 1942
P. Moinzadeh, MD,
Christopher P. Denton, PhD, FRCP, T. Krieg,
MD, &
Carol M. Black, MD, FRCP, FMedSci
158
Scleredema and Scleromyxedema. . . . . . . .
. . . . 1957
Roger H. Weenig, MD, MPH &
Mark R. Pittelkow, MD
159
Relapsing Polychondritis. . . . . . . . . . .
. . . . . . . . 1962
Camille Frances, MD
160
Rheumatoid Arthritis, Rheumatic
Fever, and Gout . . . . . . . . . . . . . . .
. . . . . . . . . . . . 1965
Warren W. Piette, MD
161
Sjogren’s Syndrome. . . . . . . . . . . . . . . . . . . . . . . . 1976
Gabor Illei, MD, PhD, MHS &
Stamatina Danielides, MD
Section 28. The Skin in Inflammatory and
Other Vascular Disorders
162
Endothelium in Inflammation and
Angiogenesis. . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . 1986
Peter Petzelbauer, MD, Robert Loewe, MD,
&
Jordan S. Pober, MD, PhD
163
Cutaneous Necrotizing Venulitis . . . . . . .
. . . . . 2003
Nicholas A. Soter, MD
164
Systemic Necrotizing Arteritis. . . . . . . .
. . . . . . . 2013
Peter A. Merkel, MD, MPH &
Paul A. Monach, MD, PhD
165
Erythema Elevatum Diutinum. . . . . . . . . .
. . . . 2029
Nneka I. Comfere, MD &
Lawrence E. Gibson, MD
166
Adamantiades–Behcet Disease. . . . . . . . . . . . . . 2033
Christos C. Zouboulis, MD, PhD
167
Kawasaki Disease. . . . . . . . . . . . . . .
. . . . . . . . . . . 2042
Anne H. Rowley, MD
168
Pigmented Purpuric Dermatoses. . . . . . . .
. . . . 2049
Theresa Schroeder Devere, MD &
Anisha B. Patel, MD
169
Cryoglobulinemia and
Cryofibrinogenemia. . . . . . . . . . . . . .
. . . . . . . . . . 2055
Holger Schmid, MD, MSc PD &
Gerald S. Braun, MD
170
Raynaud Phenomenon. . . . . . . . . . . . . .
. . . . . . . 2065
John H. Klippel, MD
171
Malignant Atrophic Papulosis
(Degos Disease) . . . . . . . . . . . . . . .
. . . . . . . . . . . . 2072
Dan Lipsker, MD, PhD
172
Vascular Malformations. . . . . . . . . . . .
. . . . . . . . 2076
Laurence M. Boon, MD, PhD &
Miikka Vikkula, MD, PhD
173
Cutaneous Changes in Peripheral
Arterial Vascular Disease. . . . . . . . . .
. . . . . . . . . 2094
Veerendra Chadachan, MD
Steven M. Dean, DO, FACP, RPVI, &
Robert T. Eberhardt, MD, FACC, FSVM, RPVI
174
Cutaneous Changes in Peripheral
Venous and Lymphatic Insufficiency. . . . . .
. . . 2110
Craig N. Burkhart, MD, Chris Adigun, MD,
&
Claude S. Burton, MD
Section 29. Bacterial Disease
175
General Considerations of Bacterial
Diseases. 2121
Noah Craft, MD, PhD, DTMH
176
Superficial Cutaneous Infections
and Pyodermas. 2128
Noah Craft, MD, PhD, DTMH
177
Gram-Positive Infections Associated
with Toxin Production. 2148
Jeffrey B. Travers, MD, PhD &
Nico Mousdicas, MBChB, MD
178
Non-Necrotizing Infections of the
Dermis and Subcutaneous Fat:
Cellulitis and Erysipelas. 2160
Adam D. Lipworth, MD,
Arturo P. Saavedra, MD, PhD, MBA,
Arnold N. Weinberg, MD, &
Richard Allen Johnson, MDCM
179
Necrotizing Soft Tissue Infections:
Necrotizing Fasciitis, Gangrenous
Cellulitis, and Myonecrosis . 2169
Adam D. Lipworth, MD,
Arturo P. Saavedra, MD, PhD, MBA,
Arnold N. Weinberg, MD, &
Richard Allen Johnson, MDCM
180
Gram-Negative Coccal and Bacillary
Infections. 2178
Myron S. Cohen, MD,
William A. Rutala, BS, MS, PhD, MPH, &
David J. Weber, MD, MPH
181
The Skin in Infective Endocarditis,
Sepsis, Septic Shock, and Disseminated
Intravascular Coagulation. 2194
Laura Korb Ferris, MD, PhD & Joseph C.
English, MD
182
Bartonellosis. 2201
Timothy G. Berger, MD & Francisco G.
Bravo, MD
183
Miscellaneous Bacterial Infections with
Cutaneous Manifestations. 2210
Scott A. Norton, MD, MPH, MS
184
Tuberculosis and Infections with
Atypical Mycobacteria. . . . . . . . . . . . . . .
. . . . . . . 2225
Aisha Sethi, MD
185
Actinomycosis, Nocardiosis, and
Actinomycetoma
. 2241
Francisco G. Bravo, MD, Roberto Arenas, MD,
&
Daniel Asz Sigall, MD
186
Leprosy . 2253
Delphine J. Lee, MD, PhD, FAAD,
Thomas H. Rea, & Robert L. Modlin, MD
187
Lyme Borreliosis. 2263
Meera Mahalingam, MD, PhD, FRCPath,
Jag Bhawan, MD, Daniel B. Eisen, MD, &
Linden Hu, MD
Section 30. Fungal Diseases
188
Superficial Fungal Infection. 2277
Stefan M. Schieke, MD & Amit Garg, MD
189
Yeast Infections: Candidiasis,
Tinea (Pityriasis) Versicolor, and
Malassezia (Pityrosporum) Folliculitis. 2298
Roopal V. Kundu, MD & Amit Garg, MD
190
Deep Fungal Infections. 2312
Roderick J. Hay, DM, FRCP, FRCPath, FMedSci
SECTION 31. Viral and Rickettsial Diseases
191
General Considerations of Viral Diseases.
2329
L. Katie Morrison, MD, Ammar Ahmed, MD,
Vandana Madkan, MD, Natalia Mendoza, MD, MS,
& Stephen Tyring, MD, PhD
192
Exanthematous Viral Diseases. 2337
Leah T. Belazarian, MD, Mayra E. Lorenzo, MD,
PhD, Andrea L. Pearson, MD,
Susan M. Sweeney, MD, & Karen Wiss, MD
193
Herpes Simplex . 2367
Adriana R. Marques, MD & Jeffrey I.
Cohen, MD
194
Varicella and Herpes Zoster. 2383
Kenneth E. Schmader, MD & Michael N.
Oxman, MD
195
Poxvirus Infections . 2402
Caroline Piggott, MD, Sheila Fallon
Friedlander, MD,
& Wynnis Tom, MD
196
Human Papilloma Virus Infections . 2421
Elliot J. Androphy, MD & Reinhard
Kirnbauer, MD
197
Human T-Lymphotropic Viruses . 2434
Erwin Tschachler, MD
198
Cutaneous Manifestations of Human
Immunodeficiency Virus Disease. 2439
Lily Changchien Uihlein, MD, JD,
Arturo P. Saavedra, MD, PhD, MBA, &
Richard Allen Johnson, MDCM
199
The Rickettsioses, Ehrlichioses, and
Anaplasmoses. 2456
Sandra A. Kopp, MD, Analisa V. Halpern, MD,
Justin J. Green, MD & Warren R. Heymann,
MD
SECTION 32. Sexually Transmitted Diseases
200 Syphilis.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2471
Kenneth A. Katz, MD, MSc, MSCE
201 Endemic
(Nonvenereal) Treponematoses. . . . . 2493
Nadine Marrouche, MD &
Samer H. Ghosn, MD
202 Chancroid.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2501
Stephan Lautenschlager, MD
203 Lymphogranuloma
Venereum. . . . . . . . . . . . . . . 2505
Rim S. Ishak, MD & Samer H. Ghosn, MD
204 Granuloma
Inguinale . . . . . . . . . . . . . . . . . . . . . . 2510
Abdul-Ghani Kibbi, MD, FAAD, FACP,
Ruba F. Bahhady, MD, & Myrna El-Shareef, MD
205 Gonorrhea,
Mycoplasma, and Vaginosis. . . . . . 2514
Ted Rosen, MD
SECTION 33. Infestations, Bites, and Stings
206 Leishmaniasis
and Other Protozoan
Infections. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . 2527
Joelle M. Malek, MD & Samer H. Ghosn, MD
207 Helminthic
Infections . . . . . . . . . . . . . . . . . . . . . . 2544
Kathryn N. Suh, MD &
Jay S. Keystone, MD, MSc(CTM), FRCPC
208 Scabies,
Other Mites, and Pediculosis . . . . . . . . 2569
Craig N. Burkhart, MD &
Craig G. Burkhart, MD, MPH
209 Bites
and Stings of Terrestrial and
Aquatic Life. . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . 2578
Jennifer S. Daly, MD &
Mark Jordan Scharf, MD
210 Arthropod
Bites and Stings . . . . . . . . . . . . . . . . . 2599
Robert A. Schwartz, MD, MPH &
Christopher J. Steen, MD
PART 10 Occupational Skin
Disea ses and Skin Disea ses
Due to Biologic Warfare
SECTION 34. Occupa tional Skin Diseases
211 Occupational
Skin Diseases Due to
Irritants and Allergens . . . . . . . . . . . . . . . . .
. . . . 2611
Golara Honari, MD,
James S. Taylor, MD, FAAD, & Apra Sood, MD
212 Occupational
Noneczematous Skin
Diseases Due to Biologic, Physical,
and Chemical Agents: Introduction. . . . . . . . . . 2622
Paul X. Benedetto, MD,
James S. Taylor, MD, FAAD, &
Apra Sood, MD
SECTION 35. The Skin in Bioterrorism and
Biologic Warfare
213 Cutaneous
Manifestations of Biologic,
Chemical, and Radiologic Attacks . . . . . . . . . . .
2633
Scott A. Norton, MD, MPH, MSc
PART 11 THERAPEUTICS
SECTION 36. Topical Therapy
214 Principles
of Topical Therapy . . . . . . . . . . . . . . . 2643
Aieska De Souza, MD, MS &
Bruce E. Strober, MD, PhD
215 Pharmacokinetics
and Topical Applications
of Drugs. . . . . . . . . . . . . . . . . . . . . . 2652
Hans Schaefer, PhD, Thomas E. Redelmeier, MD
Gerhard J. Nohynek, PhD, DABT, &
Jurgen Lademann, Prof. Dr. rer. nat. Dr.-Ing. habil.
216 Topical
Corticosteroids. . . . . . . . . . . . . . . . . . . . . 2659
Isabel C. Valencia, MD &
Francisco A. Kerdel, MD
217 Topical
Retinoids. . . . . . . . . . . . . . . . . . . . . . . . . . 2665
Anna L. Chien, MD,
John J. Voorhees, MD, FRCP, &
Sewon Kang, MD
218 Topical
Antibiotics. . . . . . . . . . . . . . . . . . . . . . . . . 2673
Mark W. Bonner, MD & William D. James, MD
219 Topical
Antifungal Agents. . . . . . . . . . . . . . . . . . 2677
Whitney A. High, MD, JD, MEng &
James E. Fitzpatrick, MD
220 Topical
and Intralesional Cytotoxic
Agents . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . 2685
Aieska De Souza, MD, MS,
Megan M. Moore, MD, & Bruce E. Strober, MD, PhD
221 Topical
Immunomodulators . . . . . . . . . . . . . . . . 2690
Edward M. Esparza, MD, PhD &
Robert Sidbury, MD, MPH
222 Other
Topical Medications. . . . . . . . . . . . . . . . . . 2697
Craig N. Burkhart, MD &
Kenneth A. Katz, MD, MSc, MSCE
223 Photoprotection.
. . . . . . . . . . . . . . . . . . . . . . . . . . 2707
Henry W. Lim, MD
SECTION 37. Systemic Therapy
224 Systemic
Glucocorticoids. 2714
Victoria P. Werth, MD
225 Dapsone.
2721
Joni G. Sago, MD & Russell P. Hall III, MD
226 Aminoquinolines.
2726
Susannah E. McClain, MD, Jeffrey R. LaDuca, MD, PhD
& Anthony A. Gaspari, MD
227 Cytotoxic
and Antimetabolic Agents. 2735
Whitney A. High, MD, JD, MEng &
James E. Fitzpatrick, MD
228 Retinoids.
2759
Anders Vahlquist, MD, PhD &
Jean-Hilaire Saurat, MD
229 Antihistamines.
2767
Robert A. Wood, MD
230 Antibiotics.
2776
Christopher C. Gasbarre, DO, FAAD,
Steven K. Schmitt, MD, &
Kenneth J. Tomecki, MD
231 Antiviral
Drugs. . . . . . . . . . . . . . . . . . . . . . . . . . . 2787
Dirk M. Elston, MD
232 Oral
Antifungal Agents. 2796
Reza Jacob, MD & Nellie Konnikov, MD
233 Immunosuppressive
and Immunomodulatory
Drugs. 2807
Jeffrey P. Callen, MD
234 Immunobiologicals,
Cytokines, and
Growth Factors in Dermatology. 2814
Stephen K. Richardson, MD &
Joel M. Gelfand, MD, MSCE
235 Antiangiogenic
Agents. 2827
Ricardo L. Berrios, MD, Michael Y. Bonner, BA,
Jonathan Hofmekler, BSc, &
Jack L. Arbiser, MD, PhD
236 Drug
Interactions. 2834
Stephen E. Wolverton, MD
SECTION 38. Physical Treatments
237 Phototherapy
. 2841
Jennifer A. Cafardi, MD, Brian P. Pollack, MD, PhD, &
Craig A. Elmets, MD
238 Photochemotherapy
and Photodynamic
Therapy. 2851
Herbert Hönigsmann, MD,
Rolf-Markus Szeimies, MD, PhD, &
Robert Knobler, MD
239 Lasers
and Flashlamps in Dermatology.
. . . . . 2869
Michael Landthaler, MD,
Wolfgang Bäumler, PhD, &
Ulrich Hohenleutner, MD
240 Radiotherapy
. 2890
Roy H. Decker, MD, PhD, &
Lynn D. Wilson, MD, MPH
SECTION 39. Complementary and Alternative
Dermatology
241 Complementary
and Alternative
Medicine in Dermatology. 2899
Alan Dattner, MD
SECTION 40. Surgery in Dermatology
242 Anatomy
and Approach in Dermatologic
Surgery. 2905
Sumaira Z. Aasi, MD &
Brent E. Pennington, MD
243 Excisional
Surgery and Repair, Flaps, and
Grafts. 2921
Jessica M. Sheehan, MD, Melanie Kingsley, MD, &
Thomas E. Rohrer, MD
244 Mohs
Micrographic Surgery . 2950
Joseph Alcalay, MD &
Ronen Alkalay, MD, MBA
245 Nail
Surgery. 2956
Robert Baran, MD
246 Cryosurgery
and Electrosurgery. 2968
Justin J. Vujevich, MD &
Leonard H. Goldberg, MD, FRCP
247 Surgical
Complications. 2977
Richard G. Bennett, MD
248 Mechanisms
of Wound Repair, Wound
Healing, and Wound Dressing. . . . . . . . . . . . . .
2984
Vincent Falanga, MD, FACP &
Satori Iwamoto, MD, PhD
249 Treatment
for Varicose and Telangiectatic
Leg Veins. 2997
Robert A. Weiss, MD & Margaret A. Weiss, MD
SECTION 41. Cosmetic Dermatology
250 Cosmetics
and Skin Care in Dermatology. . . . . . . . . . . . . . . . . . . . . . . . . .
. . . .
3009
Leslie Baumann, MD
251 Ablative
Lasers, Chemical Peels, and
Dermabrasion. . . . . . . . . . . . . . . . . . . . . . .
. . . . . . 3021
Elizabeth L. Tanzi, MD &
Tina S. Alster, MD
252 Cosmetic
Applications of Nonablative
Lasers and Other Light Devices . . . . . . . . . . . . .
3032
Elliot T. Weiss, MD,
Anne M. Chapas, MD, &
Roy G. Geronemus, MD
253 Liposuction.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3041
William G. Stebbins, MD, Aimee L. Leonard, MD, &
C. William Hanke, MD, MPH, FACP
254 Soft
Tissue Augmentation. . . . . . . . . . . . . . . . . . 3044
Lisa M. Donofrio, MD
255 Botulinum
Toxin. . . . . . . . . . . . . . . . . . . . . . . . . . . 3053
Richard G. Glogau, MD
256 Hair
Transplantation and Alopecia Reduction. . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . .
3061
Walter P. Unger, MD, Robin H. Unger, MD, &
Mark A. Unger, MD, CCFP
Index . I-1
沒有留言:
張貼留言
注意:只有此網誌的成員可以留言。